Improving health outcomes through SDOH

The pharmacy industry sees at least five changes

How is a charitable pharmacy different from other types of pharmacies?

Federal/state grants are not the only gateways to funding. There are close to 750 “community foundations” nationwide which are public charities dedicated to improving the lives of people in a defined local geographic area.

Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.

This study represents a rigorous, multi-state evaluation that highlights the impact of a charitable medication access program on hospital utilization for the medically under-served population.

Medication non-adherence has led to at least 100,000 preventable deaths each year and $100 billion annually in preventable healthcare costs in the United States

Once the continuous enrollment ends, it is estimated between 5 -14 million individuals will be affected

Significant improvement in glycemic control among participants demonstrates the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D

Three Healthcare Organizations Join Forces to Save Lives

Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost

The term digital divide is defined as the differences
of economic and social inequality in both access and usage of ICTs. 2, 3 Some population groups that are
affected by the digital divide include uninsured, at or below 300% of the Federal Poverty Level (FPL), lack
of internet access, etc

Patients taking opioid dosages at or above 50 MME/day are twice as likely to overdose compared to those taking 20 MME/day, and the risk further increases as the MME/day increases.

FDA approves 1 Year delay of Track & Trace requirements

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.